Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.

Pharmaceutical Executive Europe  E-News  
 
 
 
 
 
 
Survey
We asked...
If you’re planning to enter the emerging markets over the next 3 years, what will your primary entry strategy be?


Adapt current potfolio 7%
License products with an emerging market company 0%
Joint venture with another company 20%
Combination of above 53%
No plans to enter emerging markets 13%
Other 7%
You can now follow us on Twitter atTwitter.com/pharmexecdigi

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com


April 7, 2010
This week…

Personalized Medicine — Special Report
What are the challenges and opportunities presented by personalized medicine business models? How does your company overcome the financial challenges of personalized cell therapies? Find out here. Find out here.
The Changing Face of European Regulatory Affairs
Faiz Kermani explains why the EMA is confident about its future. More...
The Race to Combat Chronic Fatigue Syndrome
A race is on to find the cause of — and develop a successful treatment for —chronic fatigue syndrome. But is it being run fairly? More...
Also in the news…
Parallel Traders Framed in Europe
EMA Highlights 2009
GSK Joins Global Vaccine Alliance

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail

at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom